BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2322 related articles for article (PubMed ID: 30822194)

  • 1. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the Warburg effect: historical dogma versus current understanding.
    Vaupel P; Multhoff G
    J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Warburg Effect: Historical Dogma Versus Current Rationale.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2021; 1269():169-177. PubMed ID: 33966213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal Alliance of Hypoxia-/HIF-1α-Driven Microenvironmental Traits Promoting Cancer Progression.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2020; 1232():169-176. PubMed ID: 31893407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
    Kumar S; Donti TR; Agnihotri N; Mehta K
    Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.
    Wilde L; Roche M; Domingo-Vidal M; Tanson K; Philp N; Curry J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):198-203. PubMed ID: 29248131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
    Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
    Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
    Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
    Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to the molecular basis of cancer metabolism and the Warburg effect.
    Ngo DC; Ververis K; Tortorella SM; Karagiannis TC
    Mol Biol Rep; 2015 Apr; 42(4):819-23. PubMed ID: 25672512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.
    De Saedeleer CJ; Copetti T; Porporato PE; Verrax J; Feron O; Sonveaux P
    PLoS One; 2012; 7(10):e46571. PubMed ID: 23082126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.
    Yu L; Chen X; Wang L; Chen S
    Oncotarget; 2016 Jun; 7(25):38908-38926. PubMed ID: 26918353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamic side of the Warburg effect: glycolytic intermediate storage as buffer for fluctuating glucose and O
    van Beek JHGM
    F1000Res; 2018; 7():1177. PubMed ID: 30755789
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
    Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
    Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Flux Balance of Glucose Metabolism Clarifies the Requirements of the Warburg Effect.
    Dai Z; Shestov AA; Lai L; Locasale JW
    Biophys J; 2016 Sep; 111(5):1088-100. PubMed ID: 27602736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
    Zhao C; Wang B; Liu E; Zhang Z
    Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.